Potent antiviral activity of brequinar against the emerging Cantagalo virus in cell culture

International Journal of Antimicrobial Agents

Volumn 38, Issue 5, 2011, Pages 435-441

  Schnellrath, Laila Castro ^a   Damaso, Clarissa R ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Antiviral agent; Brequinar; Cantagalo virus; Poxvirus; Pyrimidine biosynthesis; Vaccinia virus

Indexed keywords

BREQUINAR; DIHYDROOROTATE DEHYDROGENASE; PYRIMIDINE; URIDINE; VIRUS DNA; VIRUS PROTEIN;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; CANTAGALO VIRUS; CELL CULTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA SYNTHESIS INHIBITION; DRUG TARGETING; GENE EXPRESSION REGULATION; IMMUNOFLUORESCENCE TEST; NONHUMAN; ORTHOPOXVIRUS; PRIORITY JOURNAL; PROGENY; PROMOTER REGION; REPORTER GENE; VACCINIA VIRUS; VIRUS REPLICATION;

ANIMALS; ANTIVIRAL AGENTS; BIPHENYL COMPOUNDS; CELL LINE; DNA REPLICATION; ENZYME INHIBITORS; GENE EXPRESSION REGULATION; KIDNEY; OXIDOREDUCTASES ACTING ON CH-CH GROUP DONORS; PYRIMIDINES; VACCINIA VIRUS; VIRAL PROTEINS; VIRUS REPLICATION;

EID: 81155162535     PISSN: 09248579     EISSN: 18727913     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2011.07.002     Document Type: Article

References (30)

1. C.R. Damaso, J.J. Esposito, R.C. Condit, and N. Moussatche An emergent poxvirus from humans and cattle in Rio de Janeiro State: Cantagalo virus may derive from Brazilian smallpox vaccine Virology 277 2000 439 449
2. M.L. Medaglia, L.C. Pessoa, E.R. Sales, T.R. Freitas, and C.R. Damaso Spread of Cantagalo virus to northern Brazil Emerg Infect Dis 15 2009 1142 1143
3. C.R. Damaso, S.A. Reis, D.M. Jesus, P.S. Lima, and N. Moussatche A PCR-based assay for detection of emerging vaccinia-like viruses isolated in Brazil Diagn Microbiol Infect Dis 57 2007 39 46 (Pubitemid 44914113)
4. J.C. Quixabeira-Santos, M.L. Medaglia, C.A. Pescador, and C.R. Damaso Animal movement and establishment of vaccinia virus Cantagalo strain in Amazon biome, Brazil Emerg Infect Dis 17 2011 726 729
5. B. Moss Poxviridae: the viruses and their replication D.M. Knipe, Fields virology 5th ed. 2007 Lippincott Williams & Wilkins Philadelphia, PA 2905 2946
6. D.F. Smee Progress in the discovery of compounds inhibiting orthopoxviruses in animal models Antivir Chem Chemother 19 2008 115 124
7. S.A. Reis, N. Moussatche, and C.R. Damaso FK506, a secondary metabolite produced by Streptomyces, presents a novel antiviral activity against Orthopoxvirus infection in cell culture J Appl Microbiol 100 2006 1373 1380 (Pubitemid 43725702)
8. A.K. Jordao, P.P. Afonso, V.F. Ferreira, M.C. de Souza, M.C. Almeida, and C.O. Beltrame Antiviral evaluation of N-amino-1,2,3-triazoles against Cantagalo virus replication in cell culture Eur J Med Chem 44 2009 3777 3783
9. D.M. Jesus, N. Moussatche, and C.R. Damaso In vitro activity of cidofovir against the emerging Cantagalo virus and the smallpox vaccine strain IOC Int J Antimicrob Agents 33 2009 75 79
10. C.R. Damaso, M.F. Oliveira, S.M. Massarani, and N. Moussatche Azathioprine inhibits vaccinia virus replication in both BSC-40 and RAG cell lines acting on different stages of virus cycle Virology 300 2002 79 91
11. C.R. Damaso, and N. Moussatche Inhibition of vaccinia virus replication by cyclosporin A analogues correlates with their affinity for cellular cyclophilins J Gen Virol 79 1998 339 346 (Pubitemid 28048438)
12. C.R. Damaso, and S.J. Keller Cyclosporin A inhibits vaccinia virus replication in vitro Arch Virol 134 1994 303 319 (Pubitemid 2053385)
13. H.J. Schuurman, M. Tanner, C. Pally, and B.D. Jaffee Brequinar and brequinar analogues in rat allo- and xenotransplantation Transplant Proc 30 1998 2240 2243 (Pubitemid 28399492)
14. L. Makowka, L.S. Sher, and D.V. Cramer The development of brequinar as an immunosuppressive drug for transplantation Immunol Rev 136 1993 51 70 (Pubitemid 24033098)
15. B.D. Jaffee, E.A. Jones, S.E. Loveless, and S.F. Chen The unique immunosuppressive activity of brequinar sodium Transplant Proc 25 1993 19 22 (Pubitemid 23194147)
16. S.F. Chen, F.W. Perrella, D.L. Behrens, and L.M. Papp Inhibition of dihydroorotate dehydrogenase activity by brequinar sodium Cancer Res 52 1992 3521 3527
17. X. Xu, J.W. Williams, J. Shen, H. Gong, D.P. Yin, and L. Blinder In vitro and in vivo mechanisms of action of the antiproliferative and immunosuppressive agent, brequinar sodium J Immunol 160 1998 846 853 (Pubitemid 28049326)
18. A.P. Castro, T.M. Carvalho, N. Moussatche, and C.R. Damaso Redistribution of cyclophilin A to viral factories during vaccinia virus infection and its incorporation into mature particles J Virol 77 2003 9052 9068 (Pubitemid 36936113)
19. M. Qing, G. Zou, Q.Y. Wang, H.Y. Xu, H. Dong, and Z. Yuan Characterization of dengue virus resistance to brequinar in cell culture Antimicrob Agents Chemother 54 2010 3686 3695
20. Q.Y. Wang, S. Bushell, M. Qing, H.Y. Xu, A. Bonavia, and S. Nunes Inhibition of dengue virus through suppression of host pyrimidine biosynthesis J Virol 85 2011 6548 6556
21. W.J. Waldman, D.A. Knight, L. Blinder, J. Shen, N.S. Lurain, and D.M. Miller Inhibition of cytomegalovirus in vitro and in vivo by the experimental immunosuppressive agent leflunomide Intervirology 42 1999 412 418 (Pubitemid 30122078)
22. D.A. Knight, A.Q. Hejmanowski, J.E. Dierksheide, J.W. Williams, A.S. Chong, and W.J. Waldman Inhibition of herpes simplex virus type 1 by the experimental immunosuppressive agent leflunomide Transplantation 71 2001 170 174 (Pubitemid 32105800)
23. D.L. Evers, X. Wang, S.M. Huong, K.A. Andreoni, and E.S. Huang Inhibition of human cytomegalovirus signaling and replication by the immunosuppressant FK778 Antiviral Res 65 2005 1 12 (Pubitemid 40094769)
24. M.C. Dunn, D.A. Knight, and W.J. Waldman Inhibition of respiratory syncytial virus in vitro and in vivo by the immunosuppressive agent leflunomide Antivir Ther 16 2011 309 317
25. A. Bonavia, M. Franti, E. Pusateri Keaney, K. Kuhen, M. Seepersaud, and B. Radetich Identification of broad-spectrum antiviral compounds and assessment of the druggability of their target for efficacy against respiratory syncytial virus (RSV) Proc Natl Acad Sci U S A 108 2011 6739 6744
26. D.F. Smee, P.A. McKernan, L.D. Nord, R.C. Willis, C.R. Petrie, and T.M. Riley Novel pyrazolo[3,4-d]pyrimidine nucleoside analog with broad-spectrum antiviral activity Antimicrob Agents Chemother 31 1987 1535 1541 (Pubitemid 17140807)
27. D.F. Smee, M. Bray, and J.W. Huggins Antiviral activity and mode of action studies of ribavirin and mycophenolic acid against orthopoxviruses in vitro Antivir Chem Chemother 12 2001 327 335 (Pubitemid 34467957)
28. S. Altmann, C.R. Brandt, C.J. Murphy, R. Patnaikuni, T. Takla, and M. Toomey Evaluation of therapeutic interventions for vaccinia virus keratitis J Infect Dis 203 2011 683 690
29. G.L. Fillmore, T.P. Ward, K.S. Bower, E.J. Dudenhoefer, J.D. Grabenstein, and G.K. Berry Ocular complications in the Department of Defense Smallpox Vaccination Program Ophthalmology 111 2004 2086 2093 (Pubitemid 39446729)
30. D.F. Smee, K.W. Bailey, M.H. Wong, M.K. Wandersee, and R.W. Sidwell Topical cidofovir is more effective than is parenteral therapy for treatment of progressive vaccinia in immunocompromised mice J Infect Dis 190 2004 1132 1139 (Pubitemid 39186801)